	Ebit		Date
Acadia Pharmaceuticals	USD 17.39M	18.36M	2025-12
Alaunos Therapeutics	USD -1.19M	148K	2025-09
ANI Pharmaceuticals	USD 29.13M	6.3M	2025-12
Ardelyx	USD 7.12M	19.62M	2025-09
Aurora Cannabis	CAD -44.75M	27.14M	2025-09
BioMarin Pharmaceutical	USD 198.39M	230.08M	2025-12
Bristol-Myers Squibb	USD 3.47B	567M	2025-12
Canopy Growth	CAD -14.3M	17.19M	2025-09
Corcept Therapeutics	USD 4.49M	5.73M	2025-12
Eli Lilly	USD 8.99B	1.57B	2025-12
Esperion Therapeutics	USD -16.03M	11.51M	2024-09
J&J	USD 5.11B	2.3B	2025-12
Knight Therapeutics	CAD 3.2M	1.29M	2024-09
Lexicon Pharmaceuticals	USD -49.63M	5.39M	2023-09
Merck	USD 6.24B	1.32B	2025-12
Nektar Therapeutics	USD -34.34M	3.68M	2024-09
Novartis	USD -9.19B	13.87B	2025-06
Novartis	USD 4.48B	343M	2025-09
Omeros	USD -48.15M	7.25M	2023-09
Pacira	USD 3.19M	9.96M	2025-12
Pfizer	USD 4.65B	71M	2025-12
Supernus Pharmaceuticals	USD 13.82M	74.01M	2025-12
TG Therapeutics	USD 50.49M	21.13M	2025-12

Corcept Therapeutics - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.